新的节奏技术和非侵入性方法可能改善对心脏再同步治疗的反应
1Department of Medicine and Hematology, Semmelweis University, Szentkirályi u. 46, 1088 Budapest, Hungary.
Journal of cardiovascular development and disease
|July 26, 2024
概括
心脏再同步治疗 (CRT) 可以改善心力衰竭症状,但大约30%的患者没有反应. 需要进一步的研究,以了解和克服心力衰竭中CRT不响应的情况,并减少喷射分数.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭研究研究
背景情况:
- 心脏再同步疗法 (CRT) 是治疗症状性心力衰竭的标准治疗方法,减少排气分数 (HFrEF) 的患者有导电延迟.
- 尽管基于证据的疗效,但很大一部分患者 (约30%) 不对CRT有反应.
- 最佳的医疗治疗和心室内导电障碍是考虑CRT的先决条件.
研究的目的:
- 调查那些为接受HFrEF的CRT治疗的患者的非响应率做出贡献的因素.
- 确定CRT无反应的潜在预测因子,以优化患者选择和治疗结果.
主要方法:
- 对接受CRT的HFrEF患者的临床数据的审查.
- 对患者特征,心声回声学参数和与CRT反应相关的QRS持续时间的分析.
主要成果:
- 该研究确定了与CRT无反应相关的关键临床和电生理学因素.
- 发现特定的患者子组更有可能没有从CRT中受益.
结论:
- 了解CRT不响应的预测因素对于改善患者选择和最大化治疗效益至关重要.
- 需要进一步的研究来完善患者选择标准,并探索非响应者的替代或辅助疗法.
相关概念视频
Pulse rhythm
777
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
777
Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555


